In addition to the different drugs, we also characterized the cell-type variation in p53 pathway response by employing five p53 reporter cancer cell lines that we generated and studied before, including A549 (lung), U-2 OS (bone), A375 (skin), MCF7 (breast), and 769-P (kidney) [15]. Here, TP53 is linked to cancer.